Psychedelic Medicine - Feb 5, 2026
Back to Stakeholders
Categories
2 domains / 4 areas / 2 specializations
New York University
United States
2 Trials1 Paper
The Center for Psychedelic Medicine at NYU Langone Health is directed by Dr. Michael Bogenschutz and performs health-focused research across the translational spectrum, from basic science to large-phase clinical trials. The center has three transdisciplinary areas of focus: psychiatry, medicine, and preclinical research. Currently, the team is actively investigating clinical applications for various psychedelic compounds, leading robust studies on psilocybin-assisted therapy for alcohol use disorder, major depression, and advanced cancer-related psychiatric distress.
Academic Research
1 papersPublished Papers
1
Trial Involvement
2
Distinct Focus Topics
0
Latest Publication
Feb 5, 2026
Recent Papers
Quick Facts
- Type
- academic
- HQ
- United States
- Website
- Visit